Mpox, Oncology Therapies and AI Integration Positions GeoVax for Strong Momentum ATLANTA, GA - February 5, 2025 (NEWMEDIAWIRE ...
Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
News Medical on MSN19h
Researchers discover how RNA molecules influence multiple generationsRNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...
RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies. But while health care ...
To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback